Diabetes mellitus affects more than 537 million adults globally, with projections suggesting this number will rise to 783 million by 2045. While the primary focus of diabetes management centers on blood glucose control through medication, diet, and exercise, an often-overlooked factor is the role of trace minerals in disease progression. Among these, manganese has emerged as a mineral of particular interest. Research increasingly points to manganese deficiency as a potential contributor to the development and acceleration of diabetes-related complications, including neuropathy, nephropathy, retinopathy, and cardiovascular disease. Understanding this connection opens new avenues for prevention and management strategies that extend beyond conventional glucose-centric approaches.

The Essential Roles of Manganese in Human Physiology

Manganese is a trace mineral that the body requires in small but critical amounts. It serves as a cofactor for numerous enzymes involved in key physiological processes. The human body contains approximately 10 to 20 milligrams of manganese, with the highest concentrations found in the bones, liver, pancreas, and kidneys. Despite its modest quantity, manganese influences functions ranging from bone development to blood clotting and neural activity.

Manganese as an Enzyme Cofactor

More than a dozen enzymes depend on manganese for proper activity. These include arginase, which is essential for the urea cycle and waste nitrogen removal; glutamine synthetase, which supports brain health by recycling the neurotransmitter glutamate; and pyruvate carboxylase, a critical enzyme in gluconeogenesis and glucose metabolism. The mineral also activates glycosyltransferases involved in cartilage and bone matrix synthesis, underscoring its importance in structural health.

The Antioxidant Defense System

One of the most crucial roles of manganese is its function within the mitochondrial antioxidant enzyme manganese superoxide dismutase (MnSOD or SOD2). This enzyme neutralizes superoxide radicals, highly reactive molecules produced during cellular respiration. Without adequate manganese, MnSOD activity declines, leaving mitochondria vulnerable to oxidative damage. Given that mitochondria are abundant in metabolically active tissues such as the pancreas, kidneys, and nerves, insufficient manganese can have far-reaching consequences in diabetes.

Manganese Deficiency: Prevalence and Contributing Factors

Overt manganese deficiency is rare in the general population, but suboptimal levels are more common than previously recognized. Individuals with diabetes may be at heightened risk for several reasons. Poor dietary habits, gastrointestinal issues that impair absorption, and increased urinary excretion related to hyperglycemia can all deplete manganese stores. Additionally, certain medications used in diabetes management may interfere with mineral status.

Diets low in whole foods and high in processed items often lack sufficient manganese. Refined grains, sugars, and unhealthy fats displace nutrient-dense options like nuts, seeds, legumes, and leafy greens. Over time, this pattern can lead to marginal deficiencies that may not produce overt symptoms but nonetheless compromise metabolic health.

Mechanisms Linking Manganese Deficiency to Diabetes Complications

The connection between low manganese levels and diabetes complications is multifaceted, involving disrupted insulin action, increased oxidative stress, impaired mitochondrial function, and altered glucose metabolism. Each mechanism reinforces the others, creating a cascade that accelerates tissue damage.

Impact on Insulin Secretion and Sensitivity

The pancreas relies on manganese for proper beta-cell function. Manganese-dependent enzymes participate in glucose-stimulated insulin secretion, the process by which beta cells release insulin in response to rising blood sugar. Animal studies have demonstrated that manganese deficiency reduces insulin secretion, leading to impaired glucose tolerance. Furthermore, manganese influences insulin signaling in peripheral tissues. Low manganese levels may contribute to insulin resistance by impairing the phosphorylation of insulin receptor substrates and downstream signaling pathways. This dual effect, reduced secretion combined with diminished sensitivity, creates a particularly challenging scenario for blood sugar regulation.

Oxidative Stress and Mitochondrial Dysfunction

Diabetes is characterized by chronic hyperglycemia, which drives excessive production of reactive oxygen species (ROS). Under normal conditions, MnSOD neutralizes superoxide radicals in mitochondria, protecting cells from oxidative injury. However, when manganese is scarce, MnSOD activity drops, allowing superoxide to accumulate. This oxidative stress damages cellular components, including lipids, proteins, and DNA, and triggers inflammatory pathways. Mitochondrial dysfunction further impairs ATP production, compromising the energy supply needed for cellular repair and function. Tissues with high energy demands, such as those in the nerves, kidneys, and retina, are particularly susceptible to this form of damage.

Effects on Glucose Metabolism and Gluconeogenesis

Pyruvate carboxylase, a manganese-dependent enzyme, plays a central role in gluconeogenesis, the process by which the liver produces glucose from non-carbohydrate precursors. Proper regulation of this pathway is essential for maintaining fasting blood glucose levels. Manganese deficiency may disrupt pyruvate carboxylase activity, leading to altered hepatic glucose output. While the precise implications for diabetes require further research, dysregulated gluconeogenesis is a well-established contributor to fasting hyperglycemia in type 2 diabetes.

Manganese Deficiency and Specific Diabetes Complications

The downstream effects of manganese deficiency manifest in the major complications of diabetes. Each complication shares a common thread of oxidative stress and metabolic dysfunction, processes that manganese directly influences.

Diabetic Neuropathy

Peripheral neuropathy affects approximately 50% of individuals with diabetes, causing pain, numbness, and increased risk of foot ulcers and amputations. Oxidative stress within peripheral nerves is a primary driver of neural damage. MnSOD normally protects neurons from superoxide-induced injury, but reduced MnSOD activity in manganese deficiency leaves nerves exposed. Additionally, manganese supports myelin synthesis and maintenance. Demyelination, a hallmark of diabetic neuropathy, may be exacerbated by insufficient manganese. Some clinical studies have observed lower serum manganese levels in patients with diabetic neuropathy compared to those without complications, suggesting a potential biomarker role.

Diabetic Nephropathy

Kidney disease develops in 20 to 40% of people with diabetes and is a leading cause of end-stage renal disease. The kidneys are rich in mitochondria and highly susceptible to oxidative damage. Manganese deficiency may accelerate nephropathy by impairing MnSOD activity in renal tubular cells. Animal models of diabetic kidney disease have shown that manganese supplementation can reduce albuminuria, glomerular hypertrophy, and fibrosis. These protective effects are attributed to both improved antioxidant defenses and reduced inflammation. While human trials remain limited, the mechanistic evidence is compelling.

Diabetic Retinopathy

Diabetic retinopathy is a leading cause of blindness among working-age adults. Hyperglycemia-induced oxidative stress damages retinal microvasculature, leading to capillary leakage and neovascularization. The retina has exceptionally high oxygen consumption and is therefore vulnerable to mitochondrial dysfunction. Manganese-dependent antioxidant enzymes in the retina help counterbalance ROS production. Low manganese levels may tip this balance toward oxidative damage, accelerating retinopathy progression. Furthermore, manganese plays a role in the visual cycle and neurotransmitter synthesis in the retina, meaning deficiency could affect both structural integrity and visual function.

Cardiovascular Disease

Cardiovascular complications are the leading cause of morbidity and mortality in diabetes. Atherosclerosis, hypertension, and cardiomyopathy all involve oxidative stress and inflammation. Manganese contributes to vascular health through MnSOD activity in endothelial cells. Reduced MnSOD function promotes endothelial dysfunction, a precursor to atherosclerosis. Manganese also influences lipid metabolism, and deficiency has been associated with unfavorable lipid profiles. Some epidemiological studies report an inverse relationship between serum manganese levels and cardiovascular risk factors, though more research is needed to establish causality.

Epidemiological Evidence and Clinical Observations

A growing body of observational research supports the link between manganese status and diabetes complications. Studies have reported lower serum manganese concentrations in individuals with type 2 diabetes compared to healthy controls. Among those with diabetes, lower manganese levels correlate with higher HbA1c values, increased markers of oxidative stress, and a greater prevalence of microvascular complications.

A cross-sectional analysis involving adults with type 2 diabetes found that those in the lowest quartile of serum manganese had significantly higher odds of diabetic kidney disease and neuropathy compared to those in the highest quartile. Similarly, a study of diabetic patients with retinopathy revealed diminished whole-blood manganese levels relative to those without retinal involvement. These associations persist after adjusting for confounders such as age, duration of diabetes, and glycemic control, suggesting an independent effect of manganese status.

However, it is important to note that observational data cannot establish causation. Factors such as inflammation and medication use may influence manganese levels, and reverse causality remains possible. Interventional trials are needed to clarify whether correcting manganese deficiency improves complication outcomes.

Dietary Sources and Bioavailability of Manganese

Ensuring adequate manganese intake through diet is a practical and safe approach to supporting metabolic health. Manganese is widely available in plant-based foods, particularly those that are minimally processed.

  • Nuts and seeds are among the richest sources. Pecans, almonds, walnuts, pumpkin seeds, and flaxseeds provide substantial manganese per serving.
  • Whole grains such as oats, brown rice, quinoa, buckwheat, and whole wheat bread contain significant amounts, especially when consumed in their intact form.
  • Legumes including chickpeas, lentils, and kidney beans offer manganese along with fiber and protein that benefit glycemic control.
  • Leafy green vegetables like spinach, kale, and Swiss chard supply manganese, though the mineral content depends on soil quality.
  • Tea is an overlooked source, with both black and green tea contributing to manganese intake, though tannins can reduce absorption.
  • Pineapple is one of the few fruits notably high in manganese.

Bioavailability is influenced by several factors. Phytic acid, found in grains and legumes, can bind manganese and reduce absorption. However, traditional preparation methods like soaking, sprouting, and fermentation reduce phytate content and improve mineral availability. Vitamin C and other organic acids may enhance manganese absorption, while iron, calcium, and zinc compete for uptake, so balance is key.

Considerations for Supplementation

For individuals with confirmed low manganese status, supplementation may be considered under medical guidance. Manganese supplements are available in various forms, including manganese gluconate, manganese sulfate, and manganese amino acid chelates. The tolerable upper intake level for adults is 11 mg per day, and typical supplement dosages range from 5 to 10 mg. However, caution is warranted. Excessive manganese intake can accumulate in the brain, leading to neurotoxicity with symptoms resembling Parkinson disease. This risk is particularly relevant for individuals with liver disease or impaired biliary function, as bile is the primary route of manganese excretion.

Supplementation should never replace dietary improvement but may serve as an adjunct when dietary intake is insufficient and deficiency is documented. Healthcare providers can assess manganese status through blood or plasma tests, though these measures have limitations because the body tightly regulates circulating manganese levels. Red blood cell manganese content may provide a more reliable indicator of long-term status.

Integrating Manganese Awareness into Diabetes Management

Recognizing the potential role of manganese deficiency in diabetes complications expands the toolkit for clinicians and patients alike. A comprehensive approach to diabetes care includes nutritional assessment beyond macronutrients and calories. Evaluating micronutrient status, including manganese, should become a standard component of care for individuals at high risk of nutritional deficiencies, such as those with gastrointestinal disorders, those on restrictive diets, and those with poor glycemic control.

Practical recommendations for healthcare providers include:

  • Encouraging a whole-food-based diet rich in nuts, seeds, whole grains, legumes, and leafy greens, which naturally provides adequate manganese for most individuals.
  • Educating patients about food preparation methods that enhance mineral bioavailability, such as soaking grains and legumes.
  • Considering manganese testing in patients with unexplained progression of complications despite adequate glycemic control.
  • Referring to registered dietitians for personalized meal planning that addresses both macronutrient and micronutrient needs.
  • Avoiding indiscriminate supplementation without confirming deficiency, given the risks of toxicity.

Future Research Directions

Despite promising evidence, many questions remain unanswered. Large-scale prospective cohort studies are needed to clarify the temporal relationship between manganese status and complication onset. Randomized controlled trials examining the effect of manganese supplementation on complication outcomes in deficient individuals would provide the highest quality evidence. Additionally, research exploring interactions between manganese and other micronutrients, such as zinc and magnesium, could reveal synergistic effects relevant to diabetes care. Advances in biomarker development may also improve the accuracy of manganese status assessment, enabling more precise interventions.

Another emerging area is the role of manganese in epigenetic regulation. Manganese-dependent enzymes participate in DNA methylation and histone modification, processes that influence gene expression in pathways relevant to diabetes. Understanding these mechanisms could uncover new therapeutic targets.

Conclusion

Manganese is far more than a minor dietary mineral. Its contributions to insulin secretion, antioxidant defense, mitochondrial function, and glucose metabolism position it as a significant factor in the pathophysiology of diabetes and its complications. While much of the current evidence derives from mechanistic studies and observational data, the consistency of findings across multiple complication types strengthens the case for giving manganese greater attention in diabetes research and clinical practice. For patients and practitioners focused on preventing the devastating consequences of diabetes, ensuring adequate manganese intake through a nutrient-dense diet represents a low-risk, potentially high-reward strategy. As with all aspects of diabetes management, individualization is essential, and decisions regarding supplementation should be made in collaboration with a knowledgeable healthcare professional. By expanding the lens beyond glucose control alone, a more integrated approach to diabetes care may emerge, one in which trace minerals like manganese play a rightful and recognized role.